With the recent development of retinal prostheses, it is important to develop reliable techniques for assessing the safety of these devices in preclinical studies. However, the standard fixation, preparation, and automated histology procedures are not ideal. Here we describe new procedures for evaluating the health of the retina directly adjacent to an implant. Retinal prostheses feature electrode arrays in contact with eye tissue. Previous methods have not been able to spatially localize the ocular tissue adjacent to individual electrodes within the array. In addition, standard histological processing often results in gross artifactual detachment of the retinal layers when assessing implanted eyes. Consequently, it has been difficult to assess localized damage, if present, caused by implantation and stimulation of an implanted electrode array. Therefore, we developed a method for identifying and localizing the ocular tissue adjacent to implanted electrodes using a (color-coded) dye marking scheme, and we modified an eye fixation technique to minimize artifactual retinal detachment. This method also rendered the sclera translucent, enabling localization of individual electrodes and specific parts of an implant. Finally, we used a matched control to increase the power of the histopathological assessments. In summary, this method enables reliable and efficient discrimination and assessment of the retinal cytoarchitecture in an implanted eye.
Introduction
Retinal prostheses may soon become useful clinical interventions for treating various forms of severe vision loss. Certain conditions, such as retinitis pigmentosa (RP), result in the widespread degeneration of the photoreceptors in the eye; these are the cells responsible for transducing light into neural signals. However, some cells in other layers of the retina remain and are potential targets for electrical stimulation with a retinal prosthesis 1 . Early results from human clinical trials have been promising for electrode arrays implanted in the epiretinal 2, 3 , subretinal 4, 5 , and intrascleral 6 locations. These devices are made from different materials with different shapes, but they all use electrical pulses to activate the remaining viable neurons of the retina in order to create visual percepts.
Our wider group (Bionic Vision Australia) has developed a retinal implant that has progressed to a clinical pilot study with 3 RP patients implanted with suprachoroidal electrode arrays (Clinical Trial Number: NCT01603576). Figure 1A shows this suprachoroidal prototype retinal prosthesis.
. In addition to the lack of a tissue localization method, the standard formaldehyde-based fixation and processing techniques resulted in widespread artifacts and detachment of the retinal due to the differential shrinkage of the various layers of the eye (Figure 2) . Due to the non-homogeneity of the retina, it was difficult to make valid comparisons with control tissue, particularly for quantitative measurements. These combined limitations complicated accurate assessments of the potential damage caused by our implanted arrays.
Here we present novel techniques for overcoming these limitations. We have modified specialized eye fixation and processing techniques [8] [9] [10] to maintain compatibility with paraffin-based histology. We have modified standard histological and immunohistochemical stains to give comparable results, based on feedback from clinical pathologists. After rendering the scleral tissue translucent, a dye-based color-code was employed to mark the ocular tissue adjacent to each individual electrode, before removing the array from the suprachoroidal space. By marking the electrode array and the individual electrode sites, samples could be accurately collected from electrode adjacent regions. Matched samples could be gathered from the control eye in order to facilitate pairwise comparisons.
Protocol

Enucleation and Post-Fixation
This protocol assumes that the subject has been implanted unilaterally with a suprachoroidal electrode array.
1. Prepare postfix solutions in glass Schott bottles. a. Davidson's fixative solution, 2x 100 ml • 2 ml formalin (37% formaldehyde) • 10 ml glacial acetic acid (99.7%) • 35 ml ethanol (98%) • 53 ml distilled water b. 50% ethanol, 2x 100 ml c. 70% ethanol, 2x 100 ml 2. Transcardially perfuse subject with warm (37 °C) heparinized saline followed by cold (4 °C) neutral buffered formalin (10%). 3. Tie sutures at the superior limbus (or a location that is remote from the suprachoroidal array) of both eyes -in line with a rectus muscle, to serve as a landmark. 4. Enucleate eyes, maintaining any external leads from the implanted eye. 5. Place each eye in 100 ml of Davidson's fixative solution and leave to post-fix at room temperature. 6. After 18 -36 hr in Davidson's fixative, transfer to 50% ethanol (room temperature) for 6 -8 hr, then finally to 70% ethanol (room temperature). 7. Refrigerate samples at 4 °C and store until dissection.
Intact and pressurized eye globes have been stored in this manner for up to 3 months without adversely affecting the resultant histology.
Identification and Tissue Mapping
The above fixation protocol (step 1) has rendered the sclera translucent and the array is now visible -including the individual electrode sites (Figure 3 ).
1. Remove the implanted globe from ethanol and carefully trim away excess tissue, including conjunctiva and Tenon's capsule. Trim optic nerve to a 2 -3 mm length ( Figure 3A ). 2. Using a histological dye marking scheme, label the electrodes with a predefined color code, taking care not to smudge the dye.
• We chose a commercially available suite of specialized histological dye (refer to appendix). Small amounts of the dye were carefully applied with a fine tipped paint brush (Roymac size 00) to the tissue and allowed to air dry for up to 5 min. • For our purposes, we have chosen: green for the active electrode(s) that was(were) stimulated maximally, at suprathreshold levels, for the duration of the study; red for other active electrodes; yellow for the larger diameter return electrodes; and blue for additional guides and/or anatomical distance markings ( Figures 3B and 3C ).
• Some trial and error may be required to find a dye that is stable throughout the subsequent steps. For example, in Figure 4 , it can be seen that the green dye was more resilient than the red dye. Diluting the dye in 70% ethanol helps improve lipid penetration and tissue coating.
• It is useful to sketch or photograph the dyed globe for future reference.
3. Return to 70% ethanol to dehydrate the dye. 4. Repeat step 2.1 for the unimplanted control globe. 5. Using the sutures from step 1.3, align the control eye and the implanted eye as a mirrored pair. 6. Place a silicone template (with the same dimensions as the electrode array) in the mirrored location on the control eye as the implant is located on implanted eye (N.B. the translucent sclera and the dye markings from step 2.2 allow ready visualization of the implanted array position). 7. Perform steps 2.2 and 2.3 for the control eye, so that each implanted electrode site has a control pair in an anatomically comparable (i.e. mirror matched equivalent) location. 3. Perform antigen retrieval using 0.01% citrate buffer, pH 6 at 75 -80 °C (20 min) and allow to cool in 0.01% citrate buffer solution (20 min). 4. Wash sections in phosphate buffered saline (PBS) (2x 5 min). 5. Permeabilize the cell membrane in wash buffer solution (10 min). 6. Incubate in serum block solution (2 hr). 7. Incubate sections in a single primary antibody diluted in antibody diluent (10% normal goat serum/0.1% Triton X-100/PBS) (overnight in fridge). The titre of each primary antibody used is shown in Table 1 . 8. After overnight incubation, wash sections in wash buffer solution (5x 3 min). From this point on, keep sections in the dark. 9. Incubate sections in the corresponding secondary antibody at a titre of 1:500 for a specific duration (see Table 1 for details). Figure 4 shows a representative section obtained from cutting the sample depicted in Figure 3 . The section was cut at 5 μm thickness and stained with H&E according to the protocols described above. The gross shape of the sample strip is preserved with minimal differential tissue artifacts ( Figure 4A ). Both dye markings were visible on the sclera, although the green dye was more resilient than the red (Figure 4B) . The retinal layers were not artifactually detached and the retinal morphology is preserved ( Figure 4C) . The retinal tissue adjacent to the dye markings, which corresponds to the location of the electrodes in the array, can be readily identified. Masson's trichrome blue; the Biebrich scarlet-acid fuchsin solution stains muscle fibers red, while the aniline blue stains the collagen, in this case sclera, blue. D) PAS; glycoprotein components of basement membrane and connective tissue components are stained purple, while the haematoxylin counterstains cell nuclei purple. E) Perls' Prussian blue; at the site of haemorrhage, the formation of haemosiderin from degraded red blood cells and release of iron complexes produces a purple color while the addition of neutral red stain colors lysosomes red. F) GS; this neurotransmitter degrading enzyme found in Müller cells 13 (green), can be seen extending in both directions with the Müller cell bodies in the inner nuclear layer and Müller cell endfeet forming the inner limiting membrane. G) NF-200; this heavy chain cytoskeletal protein (green) found in the cell soma and processes, crosslinks with other neurofilaments to maintain the structure of neurons 14, 15 . Ganglion cells and their axons can be seen in the ganglion cell layer and nerve fiber layer, while axons of horizontal cells located at the outer boarder of the inner nuclear layer in the feline retina, are also highlighted. Counterstaining with DAPI (blue) allows visualization of retinal layers. H) GFAP; this cytoskeletal protein (red) proliferated in Müller cells and astrocytes during gliosis 16 , can be seen lining the nerve fiber layer with Müller cells forming thin extensions through the inner to outer retinal layers. Counterstaining with DAPI (blue) allows for visualization of the retinal layers. Scale bar = 50 μm in all panels. The inner retina is shown at the top of each image; the outer retina is shown at the bottom of each image, excluding Panel E, which shows subscleral reaction.
Representative Results
Discussion
Assessing the safety of the implant is a primary consideration for preclinical studies. Before a retinal prosthesis can be implanted in humans it is essential to verify that it will not cause any harm. This requires an assessment of both the implant biocompatibility [17] [18] [19] [20] [21] [22] [23] as well as any potential damage that could be caused by chronic electrical stimulation [24] [25] [26] . Experience with similar neural prostheses, such as the cochlear implant, provides insight into the broad range of stimulation, and physical, parameters that do not cause tissue damage 27 . However, the retina has different characteristics to other implantation sites and therefore precise safety limits (such as maximum charge density) cannot be assumed from previous studies in other systems. Charge densities are highest at the active electrode sites and this corresponds with the greatest . It has been used with thin-film polyamide arrays 7, 31 and also thin-film silicone/Pt arrays 32 . Some retinal prosthesis studies employed "bullet shaped" electrodes with intrascleral implantations 33 . The present technique should be effective for assessing this type of electrode arrays. Feline eyes with thin sclera (thickness at posterior pole 90 -200 μm) allowed visualization of individual electrodes in an array. However, even if individual electrodes were not visible, their positions could be readily inferred using a silicone template when the outline of the array can be seen (similar to that used in step 2.6).
The dye mapping limits the need to obtain non-relevant tissue sections as only sections with the dye present are obtained. The ability to accurately infer electrode position not only allows relevant histopathological analysis and greater statistical power, but has a major impact on time and cost management by reducing the quantity of slides and blades used as well as the cost of labor. The use of dye that is adherent and can withstand tissue processing whilst also being visible in unstained tissue sections is an important initial consideration. Knowledge of the location of the dye and orientation of the tissue at dissection and during embedding assists the cutting process. This includes correctly orientating the block to achieve a section that is not obliquely cut and gives a full representation of the tissue. It is therefore important that the person performing the cutting is present at the time of dye application, dissection and embedding.
The overall protocol is robust to minor alteration, particularly with fixation timings. However, the eye dissection and dye marking steps are delicate procedures that benefit from good manual dexterity to avoid damaging the specimen. Whilst Davidson's fixative has proved effective for reducing artifactual detachment of the retina near an implant, it does not prevent direct mechanical damage during dissection. Davidson's fixative was not readily compatible with some special histological and immunohistochemical procedures. Therefore there was a need to modify/optimize these steps as detailed above. Incremental changes in staining times and concentrations were made until the optimum result was achieved -for more details, refer to the supplementary materials.
Quantification of retinal histology remains problematic. The retina is non-homogeneous and both the thickness and the cell density change with increasing distance from area centralis 34, 35 . Therefore, neighboring tissue within the implanted eye cannot be used for comparisons and a control eye is employed instead. Pairwise matching of each section with the control eye gives us a more powerful statistical comparison of pathological changes; efficacy and safety outcomes with retinal prosthetics are better assessed when comparing the fellow eyes in a subject 36 . Special care must be taken to minimize oblique cutting as this would affect quantification.
In summary, the methods described above have significantly improved our histopathological analysis, which in turn has led to a more efficient preclinical workflow. The results of preclinical studies using these methods directly led to a clinical trial in which 3 RP patients have been safely implanted with suprachoroidal retinal prostheses. These methods are relevant both to retinal stimulators and other ocular implants where the pathological response to long term implantation needs to be evaluated. This method provided worthwhile advantages for maintaining the cytoarchitecture and registration of the pathology to regions of interest on the implant. Although not specifically tested, a modification of these procedures may be used in other species and other anatomical locations, particularly where an array is implanted superficially.
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